Clinical Trial Update: Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing tofacitinib to methotrexate for psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Globe Pharmaceuticals Limited | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED